Blog
CRISPR-based therapy shows promise for reducing hereditary angioedema attacks
Hereditary angioedema, a C1 inhibitor deficiency that is caused by
Hereditary angioedema, a C1 inhibitor deficiency that is caused by
Kidney cancer is one of the most common types of
Researchers have used CRISPR/Cas9 technology to engineer donor T cells
CAR T cells currently in clinical use are designed to
CAR T cells currently in clinical use are designed to
A team led by researchers at Massachusetts General Hospital has
A CAR-T cell therapy designed to target a cellular protein
A group of researchers has taken a new approach to
Inherited retinal diseases are characterized by dysfunction and degeneration of